SEO URLwww.firestrike.ai/deals/cspc-astrazeneca-acquisition-2026
acquisitionAnnounced · Feb 2, 2026BiotechnologySource · CredibleArticle · Factual
AstraZeneca acquires CSPC
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$1.2B
Target
CSPC
Acquirer
AstraZeneca
Full Acquisition
Status
Pending
AstraZeneca agreed to acquire CSPC. Reported deal value: $1.2B. Status: Pending. Sector: Biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-02-02. Figures and status may change as filings and press coverage update.
For the deal , AstraZeneca will make an upfront payment of $1.2 billion to CSPC , with the latter eligible to receive development and regulatory-based milestone payments of up to $3.5 billion across all eight programs
Deal timeline
Announced
Feb 2, 2026 · nasdaq.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $1.2B. Figures and status may change as sources update.
Sources: nasdaq.com · Primary article · FireStrike proprietary index